Imugene financial indicator trend analysis is infinitely more than just investigating Imugene recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Imugene is a good investment. Please check the relationship between Imugene Current Deferred Revenue and its Common Stock accounts. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imugene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Current Deferred Revenue vs Common Stock
Current Deferred Revenue vs Common Stock Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Imugene Current Deferred Revenue account and
Common Stock. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Imugene's Current Deferred Revenue and Common Stock is 0.98. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Common Stock in the same time period over historical financial statements of Imugene, assuming nothing else is changed. The correlation between historical values of Imugene's Current Deferred Revenue and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Imugene are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Current Deferred Revenue i.e., Imugene's Current Deferred Revenue and Common Stock go up and down completely randomly.
Correlation Coefficient | 0.98 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.
Common Stock
Most indicators from Imugene's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Imugene current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imugene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Selling General Administrative is likely to gain to about 47.3
M in 2024.
Issuance Of Capital Stock is likely to gain to about 57.5
M in 2024
Imugene fundamental ratios Correlations
Click cells to compare fundamentals
Imugene Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Imugene fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Imugene Stock Analysis
When running Imugene's price analysis, check to
measure Imugene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imugene is operating at the current time. Most of Imugene's value examination focuses on studying past and present price action to
predict the probability of Imugene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imugene's price. Additionally, you may evaluate how the addition of Imugene to your portfolios can decrease your overall portfolio volatility.